Lex Aurum Advisors, LLC Pfizer Inc Transaction History

Lex Aurum Advisors, LLC

$400 Million
Q2 2024

A detailed history of Lex Aurum Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Lex Aurum Advisors, LLC holds 12,586 shares of PFE stock, worth $373,300. This represents 0.09% of its overall portfolio holdings.

Number of Shares

12,586

Previous 12,196 3.2%

Holding current value

$373,300

Previous $338,000 4.14%

% of portfolio

0.09%

Previous 0.09%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$25.26 - $29.6 $9,851 - $11,544	390 Added 3.2%	12,586 $352,000
Q1 2024 Apr 10, 2024	BUY	$25.89 - $29.73 $40,828 - $46,884	1,577 Added 14.85%	12,196 $338,000
Q4 2023 Jan 10, 2024	SELL	$26.13 - $33.94 $9,328 - $12,116	-357 Reduced 3.25%	10,619 $305,000
Q3 2023 Oct 16, 2023	SELL	$32.09 - $37.51 $129,675 - $151,577	-4,041 Reduced 26.91%	10,976 $364,000
Q2 2023 Jul 25, 2023	BUY	$36.12 - $41.79 $136,533 - $157,966	3,780 Added 33.64%	15,017 $550,000
Q1 2023 Apr 11, 2023	SELL	$39.39 - $51.28 $15,322 - $19,947	-389 Reduced 3.35%	11,237 $458,000
Q4 2022 Jan 23, 2023	BUY	$41.75 - $54.5 $10,813 - $14,115	259 Added 2.28%	11,626 $0
Q3 2022 Oct 17, 2022	BUY	$43.76 - $53.42 $3,982 - $4,861	91 Added 0.81%	11,367 $497,000
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $23,032 - $27,309	-495 Reduced 4.21%	11,276 $591,000
Q1 2022 May 04, 2022	SELL	$45.75 - $56.69 $52,383 - $64,910	-1,145 Reduced 8.86%	11,771 $609,000
Q4 2021 Jan 24, 2022	SELL	$41.32 - $61.25 $9,462 - $14,026	-229 Reduced 1.74%	12,916 $763,000
Q3 2021 Nov 03, 2021	SELL	$39.25 - $50.42 $2,786 - $3,579	-71 Reduced 0.54%	13,145 $565,000
Q2 2021 Jul 19, 2021	BUY	$35.91 - $40.68 $88,697 - $100,479	2,470 Added 22.99%	13,216 $518,000
Q1 2021 Apr 22, 2021	BUY	$33.49 - $37.77 $15,472 - $17,449	462 Added 4.49%	10,746 $389,000
Q4 2020 Jan 20, 2021	BUY	$33.47 - $42.56 $2,142 - $2,723	64 Added 0.63%	10,284 $379,000
Q3 2020 Oct 22, 2020	BUY	$31.75 - $37.25 $27,114 - $31,811	854 Added 9.12%	10,220 $375,000
Q2 2020 Jul 22, 2020	BUY	$30.12 - $36.54 $1,686 - $2,046	56 Added 0.6%	9,366 $306,000
Q1 2020 Apr 22, 2020	BUY	$27.03 - $38.62 $27,381 - $39,122	1,013 Added 12.21%	9,310 $304,000
Q4 2019 Jan 27, 2020	BUY	$32.92 - $37.36 $25,085 - $28,468	762 Added 10.11%	8,297 $325,000
Q3 2019 Oct 17, 2019	BUY	$32.49 - $42.13 $97 - $126	3 Added 0.04%	7,535 $271,000
Q2 2019 Jul 19, 2019	SELL	$36.98 - $41.52 $332 - $373	-9 Reduced 0.12%	7,532 $326,000
Q1 2019 May 03, 2019	BUY	$37.5 - $41.2 $16,987 - $18,663	453 Added 6.39%	7,541 $320,000
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $538 - $614	14 Added 0.2%	7,088 $309,000
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $13,477 - $16,347	-391 Reduced 5.24%	7,074 $312,000
Q2 2018 Aug 07, 2018	BUY	$32.98 - $35.16 $98 - $105	3 Added 0.04%	7,465 $271,000
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $37,749 - $43,794	-1,183 Reduced 13.68%	7,462 $265,000
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $287,532 - $305,082	8,645	8,645 $316,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lex Aurum Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lex Aurum Advisors, LLC with notifications on news.

Account

Lex Aurum Advisors, LLC Pfizer Inc Transaction History